Lately, the anti-coagulant drug Xarelto has come under fire for being less safe than its competitors. Several lawsuits have been filed against the drug’s manufacturer, Janssen Research & Development in the past few months. Patients taking the drug are experiencing “bleeding events” that are irreversible.
Hattie Delville-Goodwin, grandmother to Ashlie Fluitt, was prescribed Xarelto for the condition of deep-vein thrombosis. To the layman, this condition is also known as a blood clot. Within three months of being prescribed the medication, Goodwin was dead. The cause of death was a bleeding event linked to the drug Xarelto.
Xarelto was supposed to be a godsend for those needing to take blood thinners. It did not require the constant monitoring of diet and other factors that it’s competitor Coumadin required. For those patients and providers wishing for a medication that did not have these requirements, Xarelto fit the bill nicely.
However, Coumadin had one thing that Xarelto did not. In the event of a bleeding event, a physician could prescribe an infusion of vitamin K to reverse the effects. However, Xarelto has no such antidote.
This is what claimed the life of Delville-Goodwin. When she developed a bleed in her brain, doctors were unable to use vitamin K to attempt to bring the bleed under control.
The lawsuit alleges that the makers of Xarelto failed to warn their consumers of the risks associated with the drug over those of its competitors. Another allegation states that the promise of less monitoring is false because, without an antidote, more monitoring would be required.
This lawsuit is one of the 3,000 that have been filed against the makers of the drug. Class action lawsuits are scheduled to begin in the year 2017.
If you or someone you love has suffered injury from taking the prescribed drug Xarelto, contact the law offices of John Foy & Associates. Our “Strong Arm” attorneys will represent you to get you the compensation that you deserve. Contact us today.